Summary Mechanisms of resistance to the active metabolite 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) of the drug 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) were studied in three human cell lines with differing amounts of the repair enzyme 06-alkylguanine-DNA alkyltransferase (06AT). The lines were HT29 (Mer+Rem+), A549 (Mer+Rem-) and VA13 (Mer-). The ability to repair 06 methylguanine was directly related to resistance to MTIC (HT29 ID50 650 pmol -1, A549 ID50 210 pmol -1, VA1 3 ID50 15 pmol -1). MTIC produced DNA single strand breaks over the range of one log of cell kill, but depletion of cellular NAD levels could not be detected until there was greater than 95% cell kill. Inhibitors of the repair enzyme adenosine diphosphoribosyl transferase (ADPRT) potentiated killing by 2-fold in the Mer+ cell lines but not the Mer-line. The enhancement was directly proportional to an increase in DNA strand breaks but not a change in their half-life. Therefore resistance to the clinically used methylating agent MTIC can be partly overcome by inhibiting ADPRT but a role for ADPRT as a suicide mechanism in response to alkylating agent damage is unlikely.
One of the few active drugs in the treatment of malignant melanoma (Comis, 1976) and a component of sarcoma treatment regimens (Gottlieb et al., 1976) is the substituted triazene 5-(3,3-dimethyl-1 -triazeno)imidazole-4-carboxamide (DTIC). The mechanism of action is thought to involve metabolic N-demethylation to give the cytotoxic monomethyl triazene 5-(3-methyl-I -triazeno)imizadole-4-carboxamide (MTIC), which can methylate N-7 sites of guanine in DNA (Preussman & von Hodenburg, 1970) .
Because de novo or secondary resistance to DTIC is a common problem, we have investigated the mechanisms of resistance to killing and ways to potentiate cytotoxicity in human tumour cell lines.
Alkylation of DNA at the 06 position of guanine may be a particularly important lesion in determining cellular sensitivity to methylating agents (Erickson et al., 1980) . Human tumour cells which possess the suicide repair enzyme 06-alkylguanine-DNA alkyltransferase (O6AT) can remove 06 alkyl lesions by an error-free repair mechanism and are much more resistant to methylating agents than cells deficient in this enzyme (Harris et al., 1983) . Cell lines capable of supporting the growth of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) damaged adenovirus are also resistant to MNNG cytotoxicity, possess O6AT and are defined as having the Mer+ phenotype (Scudiero et al., 1984) . Mer-tumour (Scudiero et al., 1984) .
The Mer phenotypes also correlate with sensitivity to crosslinking nitrosoureas such as 1 ,3-bis(2-chloroethyl)-lnitrosourea (BCNU) and 1-(2-chloroethyl)-1-nitrosourea (CNU) and the methylating agent methyl methanesulphonate (MMS). DNA crosslinking by chloroethylnitrosoureas is believed to involve the initial formation of a monoadduct at the 06-position of guanine residues. Removal of this monoadduct by 06AT prevents crosslink formation (Erickson et al., 1980) . MTIC has recently been shown to alkylate DNA in the guanine-06 position in vivo (Meer et al., 1986) Methylating agents also interact with another component of DNA repair-poly ADP-ribose polymerase, or adenosine diphosphoribosyl transferase (ADPRT) (Durkacz et al., 1980) . This enzyme is absolutely dependent on DNA strand breaks for activity and catalyses the conversion of nicotinamide adenine dinucleotide (NAD) to poly ADP-ribose, which covalently modifies numerous nuclear proteins (Creissen & Shall, 1982) . Inhibition of ADPRT activity with nicotinamide analogues, such as 3-aminobenzamide (3AB), potentiates the killing effects of several methylating agents, and it has been postulated that this is due to the regulation of DNA ligases by ADPRT. Strand breaks are induced by the repair and spontaneous loss of methylated bases in DNA, and these breaks accumulate in the presence of ADPRT inhibitors. The depletion of NAD in synthesizing poly ADP-ribose has been postulated to lead to a drop in ATP levels and hence cell death (Sims et al., 1983) .
A more potent nicotinamide analogue is 3-acetamidobenzamide (3AAB) (Purnell & Whish, 1980 3AAB was synthesized by reacting 3AB with acetic anhydride (Purnell & Whish, 1980) .
Cell survival assay
Assays were carried out in triplicate. Cells (-30 x 103) were seeded into 6-well culture dishes 1-2 days before use. Culture medium was replaced just before the addition of solutions of MTIC in DMSO. After 30 min at 37°C, medium containing or omitting 3AAB was replaced and cells were grown for about three doublings. Cells were harvested by trypsinization and counted using a Coulter ZM counter. Cell survival was assessed by the increase in number of cells, expressed as a percentage of the mean value for cultures not receiving MTIC.
DNA strand break assay An alkaline unwinding procedure was used to measure DNA strand breaks (Cavanaugh et al., 1984) . Cells were grown in 100 x 15mm tissue culture dishes to give --5 x 106 cells/dish.
At appropriate times after addition of MTIC, growth medium was aspirated, the cell layer was rinsed with ice-cold PBS and the cells were harvested using a cell scraper (Costar). The number of DNA strand breaks was calculated per alkaline unwinding unit (Cavanaugh et al., 1984) .
NAD assay Cellular NAD levels were measured using the procedure of Nisselbaum and Green(1969) . Adherent cell cultures were exposed to MTIC, and NAD levels were measured after 2h (Skidmore et al., 1979) . No change of growth medium was necessary during this time, since no active drug remained after 15 min in culture medium (Parsons et al., 1982 , and our own unpublished findings). Cell layers were rinsed with icecold PBS and harvested in 50% aqueous ethanol using a cell scraper (Costar) The assay was linear up to 500 4umol 11 MTIC, but extensive fragmentation beyond 600 jumol 1 1 prevented quantitation of strand breaks at high MTIC concentrations ( Figure 4) . Thus, over the range of concentrations likely to be relevant in vivo, there was a linear relationship between strand breaks and MTIC concentration. It has been hypothesized that inhibitors of ADPRT enhance the action of cytotoxic drugs by interfering with DNA repair (Shall, 1982) . Therefore, DNA strand breaks were measured in A549 cells exposed to 100 jimol 1 -MTIC in the absence or presence of 3AAB ( Figure 5 ). The time course of appearance of strand breaks in the absence of 3AAB was rapid and they disappeared in a biphasic manner, with an initial half-life of 50 min.
In the presence of 3AAB there was a doubling of the peak number of strand breaks detected, but their rate of disappearance was not decreased. The initial half-life of disappearance was 45 min.
Thus, the dose enhancement factor was proportional to the increase in peak number of strand breaks, not a change in half-life. 
EiJects of MTIC on NAD levels
Since the activation of ADPRT, caused by the appearance of DNA strand breaks, would result in the utilization of NAD for the synthesis of poly ADP-ribose, the dose-related effects of MTIC on NAD levels were assessed. MTIC produced a marked lowering in NAD levels in A549 cells linearly related to dose (Figure 6 ). However, this decrease was over the concentration range 1-5 mmol I-and did not occur below 1 mmol l-MTIC, a concentration associated with >95% cell killing. (Scudiero et al., 1984) . It is apparent that variations in the Mer+ phenotype (Rem-or Rem ') are associated with differences in sensitivity to MTIC. This is potentially important clinically, because the Mer-phenotype has not been convincingly demonstrated in primary human tumours. Although approximately 30% of cell lines studied are Mer-, in studies of human normal and tumour material directly, absence of O6AT is much rarer (Waldstein et al., 1982; Myrnes et al., 1984a, b; Gerson et al., 1985; Wiestler et al., 1984; Umbenhauer et al., 1985; Grafstrom et al., 1984; Wani et al., 1985) . In none of the series is absence reported, out of over 150 patient samples. Also, SV40 transformation of Mer+ cell lines can produce the Mer-phenotype (Day et al., 1980) . Therefore attempts to potentiate cell killing in Mer+ cell lines are much more important for therapeutic applications. Potentiation of MTIC toxicity by 3AAB was similar with cells of both Mer+ phenotypes. Since O6MeG is not removed from DNA by excision repair (Olsson & Lindahl, 1980) , this suggests that it is the production of AP sites, and hence DNA strand breaks, during excision repair of other bases that is important in killing Mer+ cell lines and that the level of these breaks is increased in the presence of 3AAB. These experiments were all carried out in a concentration range of drugs relevant to the proportional cell kill obtained in vivo with chemotherapy. In this cytotoxic drug range there were two observations at conflict with some current assessments of the interaction of ADPRT with inhibitors and DNA repair.
Although 3AAB doubled the amount of strand breaks at 100 pmoll-1 MTIC and produced a 2-fold dose enhancement effect, there was no change in the rate of repair of breaks. Since one major explanation of the effect of 3AAB is that DNA ligase II is not activated for DNA repair when ADPRT is inhibited (Creissen & Shall, 1982) , one would expect a decreased rate of repair. Recently, Walker et al. (1984) and Cleaver and Morgan (1985) showed that more repair patches result from DNA damage in the presence of 3AB, rather than longer patches that would occur if ligation was decreased. Similarly, Moran and Ebisuzaki (1985) found that 3AB produced an increase in strand breaks but no change in rejoining rate. Our results with MTIC are compatible with the postulate that inhibitors of ADPRT allow the action of an endonuclease on damaged DNA, producing more breaks but not changing patch size of rate of ligation.
The other proposed mechanism relating increased cell killing to the use of ADPRT inhibitors involves prevention of NAD depletion. NAD depletion does occur in methylating agent treated cells, and can ultimately lead to a decrease in intracellular ATP levels. It has been postulated that this is a suicide mechanism for badly damaged cells and that ATP depletion may allow repair to occur, but not replication (Wintersberger & Wintersberger, 1985; Carson et al., 1986; Sims et al., 1985) . Stopping the NAD drop by inhibiting ADPRT would maintain ATP levels and allow replication on a damaged template, hence potentiating the effects of DNA damage.
Although we showed that MTIC, similarly to other methylating agents, did produce a NAD drop, this only occurred at very high MTIC levels (>1 mmol I-). Thus the postulated mechanism of action of ADPRT inhibitors is unlikely to be relevant in vivo. Parsons et al. (1982) and Hayward and Parsons (1984a) produced a human melanoma cell line that was resistant to MTIC after a single high dose exposure. They found that the resistant line was able to remove 06 methylguanine lesions from its DNA or prevent their formation, much more rapidly than the parent sensitive line. Gibson et al. (1986) reported the effects of MTIC on HT29, IMR90, VA13 and BE cell lines. The former two are Mer+, the latter two Mer-. They found equal amounts of DNA strand breaks in the Mer+ and Mer-lines at equimolar doses, but MTIC was much more toxic to Mer-lines.
Although strand breaks appear linearly related to MTIC dose, the strand unwinding assay we used and the alkaline elution reported by Gibson et al. (1986) did not detect breaks at 25 moll-MTIC, a concentration producing at least 50% cell kill in Mer-cell lines. Thus, the failure of 3AAB to potentiate MTIC toxicity in the Mer-cell line implies that strand breaks or hypersensitivity to strand breaks is not a major mechanism of cell killing at low MTIC concentrations. Hayward and Parsons (1984b) also found that an MTIC sensitive melanoma cell line was potentiated far less by another ADPRT inhibitor, 3-aminobenzamide, than the parent resistant line. The use of 3AAB can therefore indicate the relative contributions of different types of DNA damage to cell killing at different MTIC concentrations.
Although the results above suggest the O6MeG lesion in DNA produced by MTIC is a killing lesion, Karran and Williams (1985) found that depleting cells of 06AT with the free methylated base 06MeG did not potentiate the cytotoxicity of nitrosoureas. The lack of potentiation of Mer-cell lines with 3AAB at low MTIC doses suggests that there may be yet another type of lethal lesion in Mer-cell lines at low drug concentrations besides 06MeG and strand breaks in DNA, or that very low residual amounts of 06AT are effective. Tisdale, using a novel triazene precursor, found a delayed elevation of ADPRT activity at 2 days in a cell line capable of differentiation. This was probably related to cell cycle effects rather than immediate DNA damage (Tisdale, 1985) . The observation that 06MeG is produced in cellular DNA by MTIC and that MTIC can be potentiated by 3AAB provides the basis for in vivo studies to potentiate crosslinking nitrosoureas by competing for O6MeG repair, and to potentiate MTIC in Mer+ cells with DNA repair inhibitors. The recent development of precursors to MTIC that are more easily activated than DTIC (Stevens et al., 1984; Wilman et al., 1984; Rutty et al., 1984) will enable this approach to be assessed clinically.
